Mineralys MLS-101-301 A RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED, PARALLEL ARM, MULTICENTER PHASE 3 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF LORUNDROSTAT IN SUBJECTS WITH UNCONTROLLED AND RESISTANT HYPERTENSION

The purpose of this clinical trial is to assess the blood pressure lowering effects of lorundrostat, taken once daily, in patients with high blood pressure.

Research

Patient

High Blood Pressure (Hypertension)

Active, not recruiting

217-545-7616

Related Profiles

John Flack

estarkey74@siumed.edu

Emily Starkey

https://clinicaltrials.gov/study/NCT06153693?term=lorundrostat&rank=2

Internal Medicine